The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs.
MDC Connects 2021: A Guide to Complex Medicines is a series of webinars exploring the opportunities and challenges presented by this new class of medicines, and takes you through the steps to take an idea from concept to the clinic.
What can be learnt from traditional lead optimisation campaigns? In this webinar, we consider how to turn a lead in to a molecule with potential to be a medicine.
The early assessment of prototype nanomedicine nano-bio interactions – Zahra Rattray (University of Strathclyde)
The interaction of colloidal gene delivery vehicles with model biomembranes – Jayne Lawrence (The University of Manchester)
The challenges of determining drug levels and PK profiles for complex drug modalities – Robert Wheller (LGC)
The early assessment of prototype nanomedicine nano-bio interactions
The interaction of colloidal gene delivery vehicles with model biomembranes
The challenges of determining drug levels and PK profiles for complex drug modalities